Glycolysis inhibition by HK2 KD had similar effects on the tumor immune microenvironment as observed in KRAS inhibition by MRTX1133, including decreased macrophage infiltration and increased CD8+ T cell infiltration and activity (Figure 3C). Here, KRAS is linked to neoplasm.